Release Details

A scientist inside the laboratory testing specimens

Biogen to Present at the Bank of America Merrill Lynch 2015 Health Care Conference

May 7, 2015

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Inc. (NASDAQ: BIIB) announced today that it will present at the Bank of America Merrill Lynch 2015 Health Care Conference. The webcast will be live on Wednesday, May 13, 2015 at 11:20a.m. PT, 2:20pm ET. To access the live webcast, please visit Biogen’s Investors section at An archived version of the webcast will be available for 14 days following the presentation.

About Biogen
Through cutting-edge science and medicine, Biogen discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hematologic conditions and autoimmune disorders. Founded in 1978, Biogen is one of the world’s oldest independent biotechnology companies and patients worldwide benefit from its leading multiple sclerosis and innovative hemophilia therapies. For product labeling, press releases and additional information about the company, please visit



Investor Relations
Karen Jewell, 781-464-2442

Stockholder Communications icon

Stockholder Communications

E-mail Alerts icon

E-mail Alerts

FAQs icon